A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
Crossref DOI link: https://doi.org/10.15252/emmm.202013105
Published Online: 2020-11-03
Published Print: 2021-01-11
Update policy: https://doi.org/10.1002/crossmark_policy
Simonis, Alexander
Theobald, Sebastian J
Fätkenheuer, Gerd
Rybniker, Jan
Malin, Jakob J https://orcid.org/0000-0002-2989-0436
Version of Record valid from 2020-11-03
Publication History
Received: 2020-07-28
Accepted: 2020-09-25
Published: 2020-11-03